Drug Trial Radar · NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Dec 15, 2025
Primary completion
Nov 12, 2027
Study completion Aug 18, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Dec 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.
Conditions
- Rheumatoid Arthritis
Interventions
AZD1163Drug
Participants will receive SC injection of one of three different doses of AZD1163 in combination with SoC (csDMARD or TNFi +/- csDMARDSoC) until Week 24.
PlaceboOther
Participants will receive SC injection of placebo matched to AZD1163 in combination with SoC (csDMARD or TNFi +/- csDMARDSoC) until Week 24.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Disease Activity Score-C-Reactive Protein (DAS28-CRP) at Week 12Time frame: Week 12
Locations
147 sites in 17 countries. Site status is shown where the registry gives one.
Research Site
Glendale, Arizona · Recruiting
Research Site
Prescott Valley, Arizona · Withdrawn
Research Site
Tucson, Arizona · Recruiting
Research Site
La Jolla, California · Recruiting
Research Site
San Dimas, California · Withdrawn
Research Site
San Leandro, California · Recruiting
Research Site
Aurora, Colorado · Recruiting
Research Site
Boynton Beach, Florida · Withdrawn
Research Site
Jacksonville, Florida · Withdrawn
Research Site
South Miami, Florida · Suspended
Research Site
Tampa, Florida · Withdrawn
Research Site
Winter Haven, Florida · Recruiting
Research Site
Marietta, Georgia · Recruiting
Research Site
Skokie, Illinois · Recruiting
Research Site
Willowbrook, Illinois · Recruiting
Research Site
Lake Charles, Louisiana · Recruiting
Research Site
Baltimore, Maryland · Recruiting
Research Site
Rockville, Maryland · Not yet recruiting
Research Site
New Bedford, Massachusetts · Recruiting
Research Site
Kansas City, Missouri · Recruiting
Research Site
St Louis, Missouri · Recruiting
Research Site
Henderson, Nevada · Recruiting
Research Site
Myrtle Beach, South Carolina · Recruiting
Research Site
Austin, Texas · Recruiting
Research Site
Baytown, Texas · Recruiting
Research Site
Houston, Texas · Recruiting
Research Site
Houston, Texas · Recruiting
Research Site
Mesquite, Texas · Recruiting
Research Site
Tomball, Texas · Recruiting
Research Site
Caba, Argentina · Recruiting
Research Site
Ciudad de Buenos Aires, Argentina · Recruiting
Research Site
Ciudad de Buenos Aires, Argentina · Recruiting
Research Site
Córdoba, Argentina · Recruiting
Research Site
San Isidro, Argentina · Recruiting
Research Site
San Miguel de Tucumán, Argentina · Recruiting
Research Site
Juiz de Fora, Brazil · Not yet recruiting
Research Site
Pelotas, Brazil · Recruiting
Research Site
Porto Alegre, Brazil · Recruiting
Research Site
Porto Alegre, Brazil · Recruiting
Research Site
Salvador, Brazil · Recruiting
Showing 40 of 147 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.